BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Circadian Technologies Limited

Circadian Technologies Limited (ASX: CIR) was listed on the Australian Stock Exchange in 1985 and provides management and funding for the development and commercialisation of Australian biomedical research.It aims to identify high potential investment opportunities from within Australian universities and research institutes, focussing on projects which have the potential to address large markets or significant unmet medical needs. Circadian is able to provide funds for further development in addition to providing the management expertise that is essential if the project is to meet its goal of commercialisation.
Circadian has shareholdings in Optiscan Imaging Limited, Metabolic Pharmaceuticals Limited and Antisense Therapeutics Limited, companies in which Circadian has been involved in providing funding and assistance in their listing. Circadian is also the largest shareholder in Zenyth Therapeutics Limited (formerly Amrad Corporation) and a significant shareholder in Avexa Limited, both Australian pharmaceutical research companies.


Contact Details:
Level 1, 10 Wallace Avenue
Toorak
Victoria
3142
Australia
Tel:61 3 9826 0399
Fax:61 3 9824 0083
Email:webmaster2@circadian.com.au
WWW:

www.circadian.com.au/




Recent Publications by Circadian Technologies Limited:

Improving health, safety, and profits in extended hours operations (shiftwork).
Circadian Technologies, Inc. (CIRCADIAN) is an international consulting...
20th April, 2005
Circadian Technologies, 24 Hartwell Avenue, Lexington, MA 02421, USA. Ind Health. 2005 Jan;43(1):201-8.
Circadian alertness simulator for fatigue risk assessment in transportation: application to reduce frequency and severity of truck accidents.
The Circadian Alertness Simulator (CAS) was developed as a practical tool...
21st July, 2004
Circadian Technologies, Inc., Lexington, MA 02421, USA. Aviat Space Environ Med. 2004 Mar;75(3 Suppl):A107-18.
A lifestyle how-to for night-shift nurses.
Lifestyle training teaches night-shift nurses the factors that impact...
22nd May, 2004
Circadian Technologies, Inc., Cambridge, Mass., USA. Nurs Manage. 2000 Sep;31(9):28.

BioNews Results for Circadian Technologies Limited:

::: Arana completes a series of humanised and improved antibodies for Vegenics' cancer treatment program
Biotech Intelligence:  Oct 2 2008 2:30PM Matching: circadian technologies
Milestone for Arana
Biotechnology News:  Oct 2 2008 7:56AM Matching: circadian technologies

Circadian Technologies Limited Patents:

US Patent No.Title
6511424 Method of and apparatus for evaluation and mitigation of microsleep events
6070098 Method of and apparatus for evaluation and mitigation of microsleep events

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 204 times since April 2007, the link to the organisation's website has been followed 42 times

Recent Search Terms used to find this page: shareholders circadian technologies 2008 | circadian technologies | .

Search for more companies in Toorak

Search for more companies in Victoria



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Circadian Technologies Limited
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.